CT Thrombectomy System Kit
Device Vte
PDI 00850291007154
General payments
$25,432,951
Research payments
$4,211,864
Through program year 2025, $25,432,951 in general payments and $4,211,864 in research payments were reported against CT Thrombectomy System Kit (Vte).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,415,172 | 17,803 |
| 2025 | Research | $679,917 | 347 |
| 2024 | General | $6,733,024 | 48,293 |
| 2024 | Research | $870,140 | 491 |
| 2023 | General | $6,715,084 | 38,020 |
| 2023 | Research | $1,261,493 | 604 |
| 2022 | General | $5,159,207 | 20,965 |
| 2022 | Research | $782,289 | 1,015 |
| 2021 | General | $3,410,464 | 2,036 |
| 2021 | Research | $618,026 | 370 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 135 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
127,117 general · 2,827 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.